Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 706 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR FDA Approves Pembrolizumab for Cutaneous Squamous Cell Carcinoma June 26, 2020 For Some Kids with Brain Cancer, Targeted Therapy is Better than... June 29, 2022 Keeping A Jasmine Plant In Your Room Reduces Anxiety, Panic Attacks... April 12, 2019 TG4001 Therapeutic Vaccination Plus Avelumab-Mediated PD-L1 Blockade Improves Tumour Microenvironment in... December 12, 2020 Load more HOT NEWS Sisters on Opposite Sides of the Country Diagnosed with Breast Cancer... Seven Extra Years EMA Recommends Granting a Conditional Marketing Authorisation for Pralsetinib Patients less likely to rate cancer care as ‘very good’ during...
